Show Canada Inc. has acquired all the assets of Trekwerk B.V.
The shareholders of Trekwerk B.V. have sold all the company's assets to Show Canada Inc. Financial details have not been disclosed.
Show Canada operates worldwide participating in production of very complex grandiose events. Founded in 1999, the company has participated in more than 800 projects of various scale in Europe, Asia and the Middle East.
Trekwerk provides the technology for the ultimate stage experience. It has designed, built and installed over one hundred theater systems worldwide such as the National Theater in Oslo, the Barbican Theater in London, Stadsschouwburg in Amsterdam and the Berliner Festspiele in Berlin. Trekwerk prides itself on their custom-made TNM Motion Control Software and innovative products for theatrical rigging.
Oaklins' team in Montreal advised the buyer in the transaction.
Contacter l'équipe de la transaction
Transactions connexes
Niscon Inc. a été acquise par SGPS ShowRig.
Niscon Inc. a été acquise avec succès par SGPS ShowRig, un fournisseur mondial de solutions de scène, de levage et d’automatisation pour le divertissement en direct. Cette acquisition renforce l’engagement de SGPS ShowRig à repousser les limites de l’innovation dans l’industrie du divertissement. En intégrant la technologie unique de contrôle de mouvement de Niscon à son portefeuille, SGPS ShowRig renforce sa capacité à offrir des solutions de pointe, précises et innovantes.
En apprendre plusFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
En apprendre plusBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
En apprendre plus